V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190009243 | 190002642 | 1.81 | null | Neo-adjuvant (N) | 2019-05-24 | 2019-06-18 | OST Euramos 1 Closed Trial - Ai | null | N | DOXORUBICIN + HD MTX | 100891579 |
| 190009245 | 190002643 | 1.76 | 84.8 | null | 2017-06-13 | 2017-06-16 | OST Euramos 1 Closed Trial - AP | 02 | null | OST AP | 101006140 |
| 190009251 | 190002644 | null | null | null | null | 2019-02-26 | PAM x 2 pre-surgery (cycles 1&2) | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100686808 |
| 190009256 | 190002645 | null | null | null | null | 2017-01-10 | EW EuroEwing 2012 Arm B VDC | null | null | EW EUROEWING 2012 ARM B VDC | 100788270 |
| 190009262 | 190002647 | 1.75 | 58.7 | Curative (C) | 2019-11-25 | 2019-11-30 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 100285155 |
| 190009264 | 190002648 | null | null | null | null | 2019-12-16 | EW EuroEwing 2012 Arm A VIDE | null | null | NB LOW/INTERM RISK GUIDELINES CARBO/ETOP | 101637856 |
| 190009265 | 190002649 | 1.68 | 75.8 | Neo-adjuvant (N) | 2016-12-23 | 2016-12-26 | null | 02 | N | CISPLATIN | 100275093 |
| 190009270 | 190002650 | 0 | 30.3 | Curative (C) | 2016-05-05 | 2016-05-30 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 100103126 |
| 190009272 | 190002651 | 1.53 | 61.2 | Neo-adjuvant (N) | 2020-04-28 | 2020-05-07 | OST Euramos 1 Closed Trial - AP | 02 | N | OST AP | 100642078 |
| 190009273 | 190002652 | 1.77 | 57 | null | 2017-12-13 | 2017-12-14 | Hydroxycarbamide | null | null | MAP | 100778582 |
| 190009277 | 190002653 | null | null | null | null | 2017-01-28 | EOX | null | null | EURAMOS TRIAL | 101613308 |
| 190009279 | 190002654 | null | null | null | null | 2017-12-20 | EW EuroEwing 2012 Arm B VDC | null | null | EW EUROEWING 2012 ARM B VDC | 101077255 |
| 190009281 | 190002655 | 1.84 | 90 | Adjuvant (A) | 2017-05-01 | 2017-05-06 | Capecitabine | N | N | OST AI | 100240395 |
| 190009291 | 190002657 | null | null | null | null | 2019-12-13 | EW EuroEwing 2012 Arm B VDC | null | null | EW EUROEWING 2012 ARM B VDC | 100709712 |
| 190009292 | 190002658 | null | null | null | 2018-03-01 | 2018-03-01 | EW EuroEwing 2012 Arm B VDC | 02 | null | EW EUROEWING 2012 ARM B VDC | 100616386 |
| 190009293 | 190002659 | null | null | null | null | 2018-06-21 | CISPLATIN + FLUOROURACIL | null | null | CISPLATIN | 101577436 |
| 190009309 | 190002662 | null | null | null | 2019-10-14 | 2019-10-15 | PAM x 2 post-surgery (cycles 3&4) | N | null | EURO-EWING | 101052435 |
| 190009313 | 190002663 | null | null | null | null | 2019-09-05 | OST Euramos 1 Closed Trial - AP | null | null | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 100069593 |
| 190009314 | 190002664 | 1.58 | 63.9 | Neo-adjuvant (N) | 2017-07-23 | 2017-08-01 | Carboplatin AUC 2 - 5 | 02 | N | DOXORUBICIN | 101072272 |
| 190009315 | 190002665 | null | null | null | null | 2019-10-13 | CAPECITABINE + TEMOZOLOMIDE | null | null | ETOPOSIDE + IFOSFAMIDE | 100987342 |
| 190009319 | 190002666 | null | null | null | null | 2017-07-06 | ECX | null | null | EURAMOS TRIAL | 100467055 |
| 190009321 | 190002667 | 1.8 | 76 | Curative (C) | 2020-07-30 | 2020-08-18 | OST Euramos 1 Closed Trial - AP | 02 | Y | OST AP | 100665152 |
| 190009325 | 190002669 | null | null | null | null | 2020-02-21 | VIDE | null | null | DOXORUBICIN + METHOTREXATE | 101413091 |
| 190009326 | 190002670 | 1.75 | 57.1 | 03 | 2017-06-07 | 2017-06-15 | EW EuroEwing 2012 Arm B VDC | 02 | N | EW EUROEWING 2012 ARM B VDC | 100858772 |
| 190009329 | 190002671 | 1.85 | null | Neo-adjuvant (N) | null | 2018-11-18 | CISPLATIN + FLUOROURACIL | null | null | METHOTREXATE HIGH DOSE | 100062057 |
| 190009332 | 190002673 | null | null | null | null | 2018-09-28 | EW EuroEwing 2012 Arm B VDC | null | null | EW EUROEWING 2012 ARM B VDC | 100433526 |
| 190009336 | 190002675 | 1.82 | 91.85 | Curative (C) | 2019-04-26 | 2019-04-26 | CARBOPLATIN + GEMCITABINE | 2 | N | NB HRNBL-1 COJEC IND COURSE A | 100703600 |
| 190009337 | 190002676 | 1.76 | 91.3 | Palliative (P) | 2018-02-12 | 2018-02-13 | Cisplatin + Doxorubicin | N | N | CISPLATIN + DOXORUBICIN | 100926469 |
| 190009339 | 190002677 | 1.8 | 73 | Curative (C) | 2018-06-24 | 2018-07-02 | Gemcitabine + Capecitabine | null | Y | IMATINIB | 100782512 |
| 190009340 | 190002678 | null | null | null | null | 2019-05-01 | CISPLATIN + RT | null | null | EURO-EWING | 101125216 |
| 190009344 | 190002679 | null | null | null | null | 2018-03-31 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 101770209 |
| 190009353 | 190002682 | 1.76 | 127 | Curative (C) | 2019-08-24 | 2019-08-29 | Dox + HD Mtx (post PAM) | N | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101223078 |
| 190009357 | 190002683 | 1.59 | 79.9 | Palliative (P) | 2018-12-20 | 2018-12-23 | Capecitabine | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101866940 |
| 190009359 | 190002684 | 1.82 | 68.9 | Palliative (P) | 2017-03-23 | 2017-03-28 | CNS ATRT Doxorubicin + GCSF | 02 | N | EURO-EWING | 100505515 |
| 190009360 | 190002685 | null | null | null | null | 2019-10-21 | CARBOPLATIN + RT | null | null | MAP | 101313484 |
| 190009362 | 190002686 | 1.81 | 57 | Curative (C) | 2019-02-11 | 2019-02-11 | Carboplatin AUC 2 - 5 | 02 | Y | MIFAMURTIDE | 101698984 |
| 190009364 | 190002687 | null | null | null | null | 2017-10-14 | Cyclophosphamide + Docetaxel | null | null | DOXORUBICIN + IFOSFAMIDE | 100694368 |
| 190009365 | 190002688 | null | null | null | null | 2015-09-18 | PAM x 2 post-surgery (cycles 3&4) | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101285967 |
| 190009370 | 190002689 | null | null | null | null | 2018-06-30 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100310839 |
| 190009381 | 190002691 | 0 | 10 | Neo-adjuvant (N) | 2018-08-13 | 2018-08-18 | EURAMOS TRIAL | 02 | N | DOXORUBICIN + METHOTREXATE | 101300358 |
| 190009383 | 190002692 | 1.62 | 61 | Neo-adjuvant (N) | 2019-12-14 | 2019-12-17 | Dox + HD Mtx (post PAM) | 01 | N | NB HRNBL-1 COJEC IND COURSE A | 101263645 |
| 190009391 | 190002693 | 1.61 | 82.5 | Curative (C) | 2019-07-16 | 2019-07-16 | PAM | 01 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100856565 |
| 190009396 | 190002696 | null | null | null | null | 2018-07-31 | VDC | null | null | MIFAMURTIDE | 101470043 |
| 190009398 | 190002698 | 1.59 | 65 | Curative (C) | 2018-07-03 | 2018-07-20 | OST Euramos 1 Closed Trial - AP | 02 | N | ETOPOSIDE + IFOSFAMIDE | 101100703 |
| 190009405 | 190002700 | 1.65 | 73.5 | Curative (C) | null | 2019-01-23 | EW EuroEwing 99 : VIDE | null | null | DOXORUBICIN + METHOTREXATE | 101728198 |
| 190009408 | 190002701 | null | null | null | null | 2017-08-01 | Capecitabine + Oxaliplatin 21day | null | null | EURO-EWING | 100768830 |
| 190009412 | 190002703 | 1.71 | 72 | Curative (C) | 2017-05-14 | 2017-06-02 | Cisplatin + Doxorubicin | 02 | Y | CISPLATIN + DOXORUBICIN | 100861683 |
| 190009413 | 190002704 | 0 | 0 | Curative (C) | 2018-05-11 | 2018-05-12 | OST Euramos 1 Closed Trial - AP | 02 | Y | OST AP | 101511972 |
| 190009415 | 190002705 | 1.64 | 81.7 | 03 | 2019-05-20 | 2019-05-20 | Trial Unspecified | N | N | NOT MATCHED | 100285785 |
| 190009416 | 190002706 | 1.74 | 82.6 | Adjuvant (A) | 2018-04-08 | 2018-04-08 | Doxorubicin 75mg/m2 | N | N | NOT MATCHED | 101804731 |